| ¿µ¹® | protein | ÇÑ±Û | ´Ü¹éÁú |
|---|---|---|---|
| ¼³¸í | ź¼Ò, ¼ö¼Ò, »ê¼Ò, Áú¼Ò, ȲÀ» ÇÔÀ¯Çϰí ÀÖ´Â À¯±âÈÇÕ¹°·Î, ¸ðµç ¼¼Æ÷ÀÇ ¿øÇüÁúÀ» ÀÌ·ç°í ÀÖ´Â ±âº» ±¸¼º¹°ÁúÀÌ´Ù. ´Ü¹éÁúÀº ±× ´ÜÀ§ÀÎ ¾Æ¹Ì³ë»êµéÀÌ ÆéƼµå°áÇÕ¿¡ ÀÇÇØ °áÇյǾî ÀÖÀ¸¸ç, º¸Åë 20°³ÀÇ ¾Æ¹Ì³ë»êµéÀÌ ´Ù¸¥ ¼ø¼¿Í Á¶¼ºÀ» °¡Áö°í ¹è¿µÇ¾î, µ¶Æ¯ÇÑ ÇϳªÀÇ ´Ü¹éÁúÀ» Çü¼ºÇÏ°Ô µÈ´Ù. |
||
| ¿µ¹® | apoptosis | ÇÑ±Û | ¼¼Æ÷ÀÚ¸ê»ç, ¾ÆÆ÷ÇÁÅä½Ã½º |
|---|---|---|---|
| ¼³¸í | ÇÕ¸ñÀûÀûÀ¸·Î ¹ßÇöµÇ´Â ÇÁ·Î±×·¥µÈ ¼¼Æ÷»ç¸¦ ¸»ÇÑ´Ù. Á¾·¡¿¡´Â ¼¼Æ÷»ç¶õ ±«»ç Áï È»ó µîÀ¸·Î ÀÎÇÏ¿© Çѹ«¸®ÀÇ ¼¼Æ÷°¡ Á×´Â °ÍÀ̶ó ÀÌÇØµÇ¾úÀ¸³ª 1972³â Kerr, Wylliie, CurrieÀÇ ¼¼ º´¸®ÇÐÀÚ°¡ ÇüÅÂÀûÀ¸·Î ¸í¹éÇÏ°Ô ´Ù¸¥ ¶Ç ÇϳªÀÇ ¼¼Æ÷»ç¸¦ ¹ß°ßÇϰí À̸¦ ¾ÆÆ÷ǪÅä½Ã½º¶ó°í Á¤ÀÇÇß´Ù. ±× µÚÀÇ ¿¬±¸¸¦ ÅëÇØ ¹ß»ý´Ü°è¿¡¼ ¾î´À ƯÁ¤¼¼Æ÷°¡ ÀÏÁ¤½Ã±â, Àå¼Ò, ¼ø¼¿¡ ÀÇÇØÁ׾À¸·Î½á Á¤»óÀûÀÎ ¹ß»ýÀÌ ¿Ï·áÇÏ´Â °ÍÀ¸·Î ¾Ë·ÁÁ³À¸¸ç Ưº°È÷ ÇÁ·Î±×·¥ ¼¼Æ÷¶ó ºÎ¸£´Â ¶§µµ ÀÖ´Ù. ¶ÇÇÑ °¡½¿»ùÀ» Áß½ÉÀ¸·Î ÇÏ´Â ¸é¿ª°èÀÇ ¹ß´Þ°úÁ¤¿¡¼µµ ÀÌ ¼¼Æ÷»ç´Â ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÑ´Ù´Â Á¡, ¿©·¯ °¡Áö º´°úÀÇ °ü·Ã¿¡ ÀÖ¾î¼ À¯ÀüÀÚ ¼öÁØÀÇ ÇØ¼®À» ÅëÇÑ ¾Ï°ü·Ã À¯ÀüÀÚ, Áõ½ÄÀ¯ÀüÀÚ µî°úÀÇ º¹ÀâÇÑ °ü·Ãµµ ¾Ë·ÁÁ® ÀÖ´Ù. ÇüÅÂÀûÀ¸·Î ±«»ç´Â ¼¼Æ÷Àüü³ª »ç¸³Ã¼°¡ ¼¼È÷ ÆØÃ¢µÇ°í ¼¼Æ÷ÁúÀÇ º¯È°¡ ¼±ÇàµÇ¸ç ÃÖÁ¾ÀûÀ¸·Î ¼¼Æ÷¸·ÀÇ ÆÄ±«°¡ ÀϾ´Âµ¥ ºñÇØ, ¼¼Æ÷ÀÚ¸ê»ç¿¡¼´Â DNAÀÇ ´ÜÆíȰ¡ ¼±ÇàµÇ°í ±× °á°ú ¿°»öÁúÀÌ ÇÙ¸·ÁÖº¯¿¡ ÀÀÁýÇÏ¿© ÇÙ³óÃà, ÇÙ¿ëÇØ°¡ ÀϾ¸ç °ÅÀÇ µ¿½Ã¿¡ ¼¼Æ÷ÀÇ Ãà¼Ò¶óµç°¡ À¶¸ð µîÀÇ ¼Ò½ÇµÇ°í °á±¹ ¼¼Æ÷ Àüü°¡ ¸·¿¡ ½×ÀÎ Å©°í ÀÛÀº ¼¼Æ÷ÀÚ¸ê»ç ¼Òü·Î ´ÜÆíȵǰí ÃÖÁ¾ÀûÀ¸·Î ºñ¿°ÁõÀûÀ¸·Î Å«Æ÷½Ä¼¼Æ÷¿¡ Ž½ÄµÈ´Ù. ¼¼Æ÷ÀÚ¸ê»ç´Â ±«»ç¿Í ´ë¸³ÀûÀ¸·Î ÀÌÇØµÇ¾î ¿ÔÁö¸¸ ÃÖ±Ù µé¾î ÀÌµé µÎ°¡Áö ¼¼Æ÷Á×À½ÀÇ ÇüÅÂÀÇ °øÅëÁ¡µµ ¸¹ÀÌ ºÎ°¢µÇ°í ÀÖ´Ù. |
||
| MSS | Marshall-Smith syndrome; massage; Medical Superintendents' Society; Medicare Statistical System; men... |
|---|---|
| CAP | camptodactyly-arthropathy-pericarditis [syndrome]; Canada Assistance Plan; capsule; captopril; catab... |
| CNBP | cellular nucleic acid binding protein |
| CRABP | cellular retinoic acid-binding protein |
| CRBP | cellular retinol-binding protein |
| IAP | Inhibitor of apoptosis protein |
|---|---|
| NAIP | Neuronal Apoptosis Inhibitor Protein |
| X-IAP | X-linked inhibitor of apoptosis protein |
| DSC | Dynamic susceptibility contrast |
| HGSHS:A | Harvard Group Scale of Hypnotic Susceptibility, Form A |
| apoptosis | <cell biology> Programmed cell death as signalled by the nuclei in normally functioning human and animal cells when age or state of cell health and condition dictates. An active process requiring metabolic activity by the dying cell, often characterised by cleavage of the DNA into fragments that give a so called laddering pattern on gels. Cells that die by apoptosis do not usually elicit the inflammatory responses that are associated with necrosis, though the reasons are not clear. Cancerous cells, however, are unable to experience the normal cell transduction or apoptosis-driven natural cell death process. See: ced mutant, bcl. (18 Nov 1997) |
|---|---|
| cellular retinoic acid binding protein | <protein> A cytoplasmic fatty acid binding protein that acts as an initial receptor for the putative morphogen, retinoic acid. (18 Nov 1997) |
| BRCA1 breast cancer susceptibility gene | This mutated (changed) version of the BRCA1 gene makes a person susceptible to developing breast cancer. (12 Dec 1998) |
| breast cancer susceptibility genes | Inherited factors that predispose to breast cancer. Put otherwise, these genes make one more susceptible to the disease and so increase the risk of developing breast cancer. Two of these genes, BRCA1 and BRCA2, have been identified (and prominently publicised). Several other genes (those for the Li-Fraumeni syndrome, Cowden disease, Muir-Torre syndrome, and ataxia-telangiectasia) are also known to predispose to breast cancer. However, since all of these known breast cancer susceptibility genes together do not account for more than a minor fraction (1/5th at most) of breast cancer that clusters in families, it is clear that more breast cancer genes remain to be discovered. (12 Dec 1998) |
| cancer, breast, susceptibility genes | Inherited factors that predispose to breast cancer. Put otherwise, these genes make one more susceptible to the disease and so increase the risk of developing breast cancer. Two of these genes, BRCA1 and BRCA2, have been identified (and prominently publicised). Several other genes (those for the Li-Fraumeni syndrome, Cowden disease, Muir-Torre syndrome, and ataxia-telangiectasia) are also known to predispose to breast cancer. However, since all of these known breast cancer susceptibility genes together do not account for more than a minor fraction (1/5th at most) of breast cancer that clusters in families, it is clear that more breast cancer genes remain to be discovered. (12 Dec 1998) |
| cancer susceptibility gene | tumour suppressor gene |
| genes, breast cancer susceptibility | Inherited factors that predispose to breast cancer. Put otherwise, these genes make one more susceptible to the disease and so increase the risk of developing breast cancer. Two of these genes, BRCA1 and BRCA2, have been identified (and prominently publicised). Several other genes (those for the Li-Fraumeni syndrome, Cowden disease, Muir-Torre syndrome, and ataxia-telangiectasia) are also known to predispose to breast cancer. Howeverm, since all of these known breast cancer susceptibility genes together do not account for more than a minor fraction (1/5th at most) of breast cancer that clusters in families, it is clear that more breast cancer genes remain to be discovered. See related entries to: BRCA1; BRCA2; Breast cancer, familial. (12 Dec 1998) |
| colourimetric caries susceptibility test | A colourimetric test for determining dental caries activity or susceptibility based on the rate of acid production by acidogenic oral microorganisms (e.g., lactobacillus) in a glucose medium, using bromcresol green as the indicator, and producing a colour change from green to yellow. Synonym: colourimetric caries susceptibility test. (05 Mar 2000) |
| susceptibility | Origin: Cf. F. Susceptibilite. 1. The state or quality of being susceptible; the capability of receiving impressions, or of being affected. 2. Specifically, capacity for deep feeling or emotional excitement; sensibility, in its broadest acceptation; impressibility; sensitiveness. <physics> Magnetic susceptibility, the intensity of magnetization of a body placed in a uniform megnetic field of unit strength. Synonym: Capability, sensibility, feeling, emotion. Source: Websters Dictionary (01 Mar 1998) |
| susceptibility testing | The determination of the ability of an antibiotic to kill or inhibit the growth of bacteria. (05 Mar 2000) |
| disease susceptibility | A constitution or condition of the body which makes the tissues react in special ways to certain extrinsic stimuli and thus tends to make the individual more than usually susceptible to certain diseases. (12 Dec 1998) |
| acute cellular rejection | Graft rejection which usually begins within 10 days after a graft has been transplanted into a genetically dissimilar host. Lesions at the site of the graft characteristically are infiltrated with large numbers of lymphocytes and macrophages which cause tissue damage. See: primary rejection. Synonym: acute rejection. (05 Mar 2000) |
| cellular | 1. Relating to, derived from, or composed of cells. 2. Having numerous compartments or interstices. Origin: L. Cellula, dim. Of cella, storeroom (05 Mar 2000) |
| cellular biology | <study> The study of cells. Implies the use of light or electron microscopic methods for the study of morphology. (18 Nov 1997) |
| cellular biophysics | Biophysics concerned with cellular processes. (05 Mar 2000) |
Synonyms : CAPTS gene product, CAS Export Factor, CSE1L Protein, Chromosome Segregation 1 Like Protein, Importin-alpha Export Receptor CAS, Export Factor, CAS, Importin alpha Export Receptor CAS
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|